Progress through innovation

With continuous improvisations and additions into product portfolio, Agilent Technologies continues to maintain a good hold over the Indian chromatography market


Rank 3

Agilent Technologies is one of the few players which has a complete portfolio of mass spectrometry techniques that spans the various application needs of the industry. In FY 2011-12, Agilent India's life sciences business is estimated to be Rs 365.7 crore as compared to `318 crore in FY 2010-11. Bulk of Agilent's Life Sciences and Chemical Analysis (LSCA) business comes from sale of its products and solutions to the pharma sector.

The expansion of LSCA Center of Excellence and the setting up of application development lab have helped it to accelerate the discovery of life science analysis work flows; both making it the largest research facility in the world.

The acquisition of Varian has broadened and strengthened Agilent's product portfolio. Similarly the decision to acquire Dako, a leading cancer diagnostics solution provider, has opened new avenues for the company.

Agilent signed a research sponsoring agreement with Amrita University for providing consumables valued at $10,000 and offers extensive service and support. The company along with Department of Science & Technology (Government of India) and Confederation of Indian Industry launched the third season of nationwide i3 innovation competition for all innovators.

Previous 1 Next
1 Comment Comment 1 - 1 of 1

Caiya 10 April 2013 at 07:41 PM

Always refreshing to hear a riatonal answer.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email